The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years

Endocrine

Volumn 45, Issue 2, 2014, Pages 230-235

  Guo, Hongwei ^a   Sun, Min ^a   He, Wei ^a   Chen, Huanhuan ^a   Li, Wen ^a   Tang, Jinmei ^a   Tang, Wei ^a   Lu, Jieli ^b   Bi, Yufang ^b   Ning, Guang ^b   Yang, Tao ^a   Duan, Yu ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Diabetes; Hypertension; Metabolic parameters; Prediabetes; Thyroid nodules

Indexed keywords

GLUCOSE;

ADULT; AGED; AGING; ARTICLE; CHINESE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THYROID NODULE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COMMUNITY-BASED PARTICIPATORY RESEARCH; DIABETES COMPLICATIONS; FEMALE; GLUCOSE; HUMANS; HYPERTENSION; LIPID METABOLISM; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NODULE;

EID: 84896723778     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9968-0     Document Type: Article

References (28)

1. S.B. Park, H.C. Choi, N.S. Joo, The relation of thyroid function to components of the metabolic syndrome in Korean men and women. J. Korean Med. Sci. 26(4), 540-545 (2011). doi: 10.3346/jkms.2011.26.4.540
2. A. Roos, S.J. Bakker, T.P. Links, R.O. Gans, B.H. Wolffenbuttel, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92(2), 491-496 (2007)
3. A.C. Waring, N. Rodondi, S. Harrison, A.M. Kanaya, E.M. Simonsick, I. Miljkovic, S. Satterfield, A.B. Newman, D.C. Bauer, Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin. Endocrinol. (Oxf) 76(6), 911-918 (2012). doi: 10.1111/j.1365-2265.2011.04328.x
4. J. Jin, R. Machekano, C.R. McHenry, The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. Am. J. Surg. 199(3), 294-297 (2010). discussion 298
5. R. Sari, M.K. Balci, H. Altunbas, U. Karayalcin, The effect of body weight and weight loss on thyroid volume and function in obese women. Clin. Endocrinol. (Oxf) 59(2), 258-262 (2003)
6. M.A. Michalaki, A.G. Vagenakis, A.S. Leonardou, M.N. Argentou, I.G. Habeos, M.G. Makri, A.I. Psyrogiannis, F.E. Kalfarentzos, V.E. Kyriazopoulou, Thyroid function in humans with morbid obesity. Thyroid 16(1), 73-78 (2006). doi: 10.1089/thy.2006.16.73
7. S. Ayturk, A. Gursoy, A. Kut, C. Anil, A. Nar, N.B. Tutuncu, Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur. J. Endocrinol. 161(4), 599-605 (2009)
8. J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 18(4), 461-464 (2008). doi: 10.1089/thy.2007.0223
9. J. Brunn, U. Block, G. Ruf, I. Bos, W.P. Kunze, P.C. Scriba, Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl). Dtsch. Med. Wochenschr. 106(41), 1338-1340 (1981). doi: 10.1055/s-2008-1070506
10. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167-1214 (2009). doi: 10.1089/thy.2009.0110
11. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus WHO/NCD/NCS/99, vol. 2nd edn. (World Health Organization, Geneva, 1999)
12. K.G. Alberti, P. Zimmet, J. Shaw, The metabolic syndrome - a new worldwide definition. Lancet 366(9491), 1059-1062 (2005)
13. T.W. Furlanetto, S. Peccin, O.M.A. de Schneider, S.A. dos Zimmer, P.S. dos Reis, S.K. Genro, E.V. Ferreira, F. Bittelbrum, A.S. Muller, R.W. Silva, Siqueira II, M.F. da Silveira, Prevalence of thyroid nodules in 40 years-old or old women. Rev. Assoc. Med. Bras. 46(4), 331-334 (2000)
14. S. Ezzat, D.A. Sarti, D.R. Cain, G.D. Braunstein, Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch. Intern. Med. 154(16), 1838-1840 (1994)
15. T.V. Bartolotta, M. Midiri, G. Runza, M. Galia, A. Taibbi, L. Damiani, G. Palermo Patera, R. Lagalla, Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler pattern in an adult population screened by real-time compound spatial sonography. Radiol. Med. 111(7), 989-998 (2006). doi: 10.1007/s11547-006-0097-1
16. L. Hegedus, H. Perrild, L.R. Poulsen, J.R. Andersen, B. Holm, P. Schnohr, G. Jensen, J.M. Hansen, The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J. Clin. Endocrinol. Metab. 56(2), 260-263 (1983)
17. S.A. Ivarsson, P.H. Persson, U.B. Ericsson, Thyroid gland volume as measured by ultrasonography in healthy children and adolescents in a non-iodine deficient area. Acta Paediatr. Scand. 78(4), 633-634 (1989)
18. S. Semiz, U. Senol, Bircan, S. Gumuslu, S. Bilmen, I. Bircan, Correlation between age, body size and thyroid volume in an endemic area. J. Endocrinol. Invest. 24(8), 559-563 (2001)
19. H.F. Zhu, Y. Yang, J.Y. Li, X.M. Li, A.G. Ma, Prevalence of thyroid nodules and influencing factors among employees of a company in Qingdao. Zhonghua Yu Fang Yi Xue Za Zhi 46(3), 228-232 (2012)
20. O. Topaloglu, F. Gokay, K. Kucukler, F.S. Burnik, T. Mete, H.C. Yavuz, D. Berker, S. Guler, Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status? Endocrine (2012). doi: 10.1007/s12020-012-9842-5
21. J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab. Syndr. Relat. Disord. 9(1), 69-75 (2011). doi: 10.1089/met.2010.0026
22. M.L. Isidro, M.A. Penin, R. Nemina, F. Cordido, Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 32(1), 79-82 (2007). doi: 10.1007/s12020-007-9012-3
23. V. Vella, L. Sciacca, G. Pandini, R. Mineo, S. Squatrito, R. Vigneri, A. Belfiore, The IGF system in thyroid cancer: new concepts. Mol. Pathol. 54(3), 121-124 (2001)
24. J.N. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab. Syndr. Relat. Disord. 7(4), 375-380 (2009). doi: 10.1089/met.2008.0062
25. R. Malaguarnera, A. Morcavallo, A. Belfiore, The insulin and igf-I pathway in endocrine glands carcinogenesis. J. Oncol. 2012, 635614 (2012). doi: 10.1155/2012/635614
26. R. Malaguarnera, F. Frasca, A. Garozzo, F. Giani, G. Pandini, V. Vella, R. Vigneri, A. Belfiore, Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J. Clin. Endocrinol. Metab. 96(3), 766-774 (2011). doi: 10.1210/jc.2010-1255
27. G. Rojo-Martinez, I. Esteva, S.R. de Adana, M. Catala, M.J. Merelo, F. Tinahones, J.M. Gomez-Zumaquero, A.L. Cuesta, F. Cardona, F. Soriguer, Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res. Clin. Pract. 65(3), 247-256 (2004). doi: 10.1016/j.diabres.2004.01.004
28. S.E. Kahn, The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am. J. Med. 108(Suppl 6a), 2S-8S (2000)